Denosumab vs Zoledronate After Lumbar Fusion
NCT05638399
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Osteopenia
Lumbar Spondylolisthesis
Interventions
DRUG:
Denosumab 60 mg/ml [Prolia]
DRUG:
Zoledronate
Sponsor
Shenzhen People's Hospital